Nifty

:

8485.65

Sensex

:

29184.37

-174.60 (-2.02%)
-631.22 (-2.12%)

Login

Nifty
Sensex

:
:

8485.65
29184.37

-174.60 (-2.02%)
-631.22 (-2.12%)

Abbott India Ltd.

Pharmaceuticals & Drugs

Rating :

91/99

BSE: 500488 | NSE: ABBOTINDIA

Watchlist

NSE BSE

14146.10

27-Mar-2020

Open
High
Low
Previous Close

14599.00
14792.00
13895.00
14392.55

Volume
Traded Value (lacs)
52 Week High
52 Week Low

12873
1833.77
16499.00
7160.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

30,030.26
50.46
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

28,345.97
0.46%
12.95

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
9.95
8.22

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
14.18
8.88

PAT CAGR (%)

10 Years
5 Years
3 Years

-
14.49
17.63

P:E (Median)

8 Years
5 Years
3 Years

35.69
37.58
37.14

P:BV (Average)

8 Years
5 Years
3 Years

13.67
13.67
13.67

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.59
22.76
22.76

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var%
Net Sales 1078 948 14% 1055 980 8% 999 845 18% 906 788 15%
Expenses 839 801 5% 851 786 8% 825 734 12% 753 682 11%
EBITDA 240 146 64% 204 194 5% 174 111 56% 153 107 43%
EBIDTM 22% 15% 19% 20% 17% 13% 17% 14%
Other Income 28 38 -26% 29 25 18% 30 22 36% 29 59 -50%
Interest 2 0 333% 2 1 250% 2 1 262% 1 2 -66%
Depreciation 15 4 280% 15 4 268% 15 4 271% 5 4 24%
PBT 251 180 39% 216 214 1% 187 129 45% 177 159 11%
Tax 64 63 2% 38 76 -50% 70 46 52% 63 59 8%
PAT 187 117 59% 178 138 30% 117 82 42% 113 100 13%
PATM 17% 12% 17% 14% 12% 10% 12% 13%
EPS 87.85 55.08 59% 83.92 64.79 30% 55.03 38.78 42% 53.27 47.10 13%

Description Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10 Nov 09
Net Sales 4,038.25 3,678.60 3,298.50 2,902.56 2,614.50 2,289.33 2,275.90 1,652.69 1,490.21 1,036.87 794.56 Net Sales Growth 13.41% 11.52% 13.64% 11.02% 14.20% 0.59% 37.71% 10.90% 43.72% 30.50% Cost Of Goods Sold 2,264.26 2,088.60 1,900.43 1,714.96 1,494.45 1,314.45 1,299.16 974.96 862.72 631.48 490.63 Gross Profit 1,773.99 1,590.01 1,398.07 1,187.60 1,120.05 974.87 976.75 677.72 627.49 405.39 303.93 GP Margin 43.93% 43.22% 42.39% 40.92% 42.84% 42.58% 42.92% 41.01% 42.11% 39.10% 38.25% Total Expenditure 3,267.34 3,074.56 2,775.10 2,507.75 2,250.77 1,978.01 2,008.62 1,451.27 1,314.83 967.43 697.24 Power & Fuel Cost - 12.61 10.26 7.74 6.98 5.96 9.08 9.06 8.37 6.97 5.10 % Of Sales - 0.34% 0.31% 0.27% 0.27% 0.26% 0.40% 0.55% 0.56% 0.67% 0.64% Employee Cost - 435.58 393.69 345.27 341.09 305.40 299.74 206.20 167.35 108.13 59.69 % Of Sales - 11.84% 11.94% 11.90% 13.05% 13.34% 13.17% 12.48% 11.23% 10.43% 7.51% Manufacturing Exp. - 14.42 11.52 13.14 11.94 11.59 18.29 6.19 4.30 25.36 20.81 % Of Sales - 0.39% 0.35% 0.45% 0.46% 0.51% 0.80% 0.37% 0.29% 2.45% 2.62% General & Admin Exp. - 267.14 239.06 205.33 191.08 152.91 192.05 113.38 111.64 48.33 28.88 % Of Sales - 7.26% 7.25% 7.07% 7.31% 6.68% 8.44% 6.86% 7.49% 4.66% 3.63% Selling & Distn. Exp. - 191.15 156.94 148.33 152.27 135.60 130.83 98.13 116.14 114.92 72.74 % Of Sales - 5.20% 4.76% 5.11% 5.82% 5.92% 5.75% 5.94% 7.79% 11.08% 9.15% Miscellaneous Exp. - 65.05 63.19 72.98 52.96 52.10 59.47 43.34 44.30 32.23 72.74 % Of Sales - 1.77% 1.92% 2.51% 2.03% 2.28% 2.61% 2.62% 2.97% 3.11% 2.44% EBITDA 770.91 604.04 523.40 394.81 363.73 311.32 267.28 201.42 175.38 69.44 97.32 EBITDA Margin 19.09% 16.42% 15.87% 13.60% 13.91% 13.60% 11.74% 12.19% 11.77% 6.70% 12.25% Other Income 115.62 113.98 118.09 60.15 51.24 48.48 49.29 22.70 19.80 35.99 29.28 Interest 6.46 2.25 3.82 2.04 2.52 0.50 0.08 0.02 0.03 0.04 0.20 Depreciation 49.71 16.92 16.19 16.43 14.44 14.94 21.93 19.49 15.00 11.25 9.01 PBT 830.36 698.85 621.48 436.49 398.01 344.36 294.55 204.60 180.16 94.14 117.38 Tax 235.21 248.52 220.26 159.84 142.76 115.40 96.10 70.29 59.77 33.21 39.87 Tax Rate 28.33% 35.56% 35.44% 36.62% 35.87% 33.51% 32.63% 32.69% 33.18% 35.28% 33.97% PAT 595.15 450.33 401.22 276.65 255.25 228.96 198.45 144.70 120.39 60.94 77.51 PAT before Minority Interest 595.15 450.33 401.22 276.65 255.25 228.96 198.45 144.70 120.39 60.94 77.51 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.74% 12.24% 12.16% 9.53% 9.76% 10.00% 8.72% 8.76% 8.08% 5.88% 9.76% PAT Growth 36.12% 12% 45% 8% 11% 15% 37% 20% 98% -21% Unadjusted EPS 280.07 211.93 188.81 130.19 120.12 107.75 93.39 68.10 56.66 44.56 56.68

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10 Nov 09
Shareholder's Funds 2,008.59 1,692.76 1,386.94 1,195.60 937.53 787.85 646.86 544.14 305.38 271.56 Share Capital 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 13.68 13.68 Total Reserves 1,959.59 1,650.56 1,352.37 1,174.35 916.28 766.60 625.61 522.89 291.71 257.88 Non-Current Liabilities 62.36 40.75 34.84 29.25 432.46 442.99 30.68 230.24 0.19 2.20 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 75.43 55.35 47.22 38.64 438.98 444.27 29.43 236.44 0.00 0.00 Current Liabilities 856.89 668.08 631.64 382.27 834.22 652.31 229.55 238.52 556.48 475.96 Trade Payables 663.52 480.62 474.69 230.14 193.56 136.22 101.35 120.90 57.75 43.11 Other Current Liabilities 89.42 81.80 77.90 86.90 59.35 53.91 44.09 41.28 40.21 14.79 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 103.96 105.66 79.05 65.23 581.31 462.18 84.11 76.35 458.52 418.06 Total Liabilities 2,927.84 2,401.59 2,053.42 1,607.12 2,204.21 1,883.15 907.09 1,012.90 862.05 749.72 Net Block 104.96 81.38 109.60 108.46 96.04 98.25 108.67 79.66 49.71 48.79 Gross Block 164.52 124.25 139.69 122.83 215.65 209.23 203.65 191.81 118.21 107.10 Accumulated Depreciation 59.56 42.87 30.10 14.37 119.61 110.98 94.98 112.15 68.50 58.31 Non Current Assets 166.85 136.12 160.41 156.49 540.81 540.48 133.23 326.64 50.57 49.15 Capital Work in Progress 0.73 2.17 6.28 2.83 3.91 1.27 0.51 0.36 0.86 0.36 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 56.69 48.91 41.53 42.47 438.62 438.94 22.88 246.62 0.00 0.00 Other Non Current Assets 4.47 3.66 3.00 2.73 2.24 2.02 1.17 0.00 0.00 0.00 Current Assets 2,760.98 2,265.47 1,893.02 1,450.63 1,663.39 1,342.67 773.86 686.26 811.48 700.56 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 606.79 585.33 500.63 370.10 384.13 359.05 263.63 254.90 128.59 102.38 Sundry Debtors 276.11 263.44 176.22 145.02 129.15 109.18 141.03 132.61 65.28 44.40 Cash & Bank 1,684.28 1,031.35 1,090.92 839.42 643.89 462.84 323.34 258.95 188.51 175.61 Other Current Assets 193.80 95.80 19.01 16.57 506.22 411.61 45.85 39.80 429.10 378.18 Short Term Loans & Adv. 93.24 289.55 106.23 79.51 488.68 397.22 41.15 33.69 427.90 377.75 Net Current Assets 1,904.09 1,597.39 1,261.38 1,068.36 829.17 690.36 544.31 447.74 255.00 224.61 Total Assets 2,927.83 2,401.59 2,053.43 1,607.12 2,204.20 1,883.15 907.09 1,012.90 862.05 749.71

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10 Nov 09
Cash From Operating Activity 499.13 152.70 307.22 248.68 214.78 155.31 101.35 24.07 46.06 37.16 PBT 698.85 621.48 436.49 398.01 344.36 294.55 214.99 180.16 94.14 117.38 Adjustment -77.46 -76.92 -37.02 -23.98 -37.19 -1.08 -9.23 1.40 6.57 4.35 Changes in Working Capital 134.41 -186.96 66.52 21.85 23.48 -28.45 -39.78 -97.28 -5.61 -46.35 Cash after chg. in Working capital 755.80 357.61 466.00 395.87 330.65 265.03 165.98 84.28 95.10 75.38 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -256.67 -204.90 -158.78 -147.20 -115.87 -109.71 -64.63 -60.21 -49.04 -38.22 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -257.00 -214.84 -155.41 -77.19 -186.72 -143.90 -58.51 5.05 -15.75 -0.83 Net Fixed Assets -38.83 19.55 -20.31 93.90 -9.06 -6.34 -11.99 -73.10 -11.61 -6.04 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -218.17 -234.39 -135.10 -171.09 -177.66 -137.56 -46.52 78.15 -4.14 5.21 Cash from Financing Activity -142.80 -102.43 -89.76 -80.29 -57.58 -42.35 -42.01 -42.02 -27.24 -23.36 Net Cash Inflow / Outflow 99.33 -164.56 62.05 91.19 -29.52 -30.94 0.83 -12.90 3.08 12.96 Opening Cash & Equivalents 37.68 202.24 140.19 49.00 78.52 109.46 108.63 70.38 69.21 56.26 Closing Cash & Equivalent 137.01 37.68 202.24 140.19 49.00 78.52 109.46 108.63 72.29 69.21

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10 Nov 09
Book Value (Rs.) 932.19 786.76 646.43 562.65 441.20 370.77 304.41 256.08 223.31 198.58 ROA 16.90% 18.01% 15.12% 13.39% 11.20% 14.22% 15.07% 12.84% 7.56% 13.64% ROE 24.66% 26.35% 21.54% 23.93% 26.54% 27.66% 24.30% 28.34% 21.12% 31.46% ROCE 37.88% 40.61% 33.96% 37.55% 39.98% 41.07% 36.11% 42.42% 32.65% 47.65% Fixed Asset Turnover 25.48 25.06 22.39 15.63 10.91 11.19 8.47 9.73 9.26 7.78 Receivable days 26.77 24.26 19.95 18.91 18.77 19.78 29.82 23.94 19.19 17.51 Inventory Days 59.14 59.93 54.07 52.03 58.54 49.21 56.51 46.40 40.41 44.36 Payable days 76.56 66.93 54.71 38.57 32.92 23.41 31.17 26.13 19.87 31.05 Cash Conversion Cycle 9.35 17.26 19.31 32.37 44.39 45.58 55.17 44.21 39.74 30.81 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 311.82 163.60 215.33 158.63 685.07 3532.82 8996.52 6006.28 2433.69 580.67

Top Investors:

l and t mutual fund trustee ltd-l and t mid cap fund

pnb metlife india insurance company limited

aegon religare life insurance company limited - ul if01203/09/10accelerate0138

Annual Reports:

News Update:

Abbott launches new inactivated quadrivalent vaccine in India
24th Feb 2020, 15:20 PM

It is the only 0.5 ml quadrivalent flu vaccine in India that has been approved for use in children below three years
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback